Thor Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Thor Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.9M	Buy	102,446 +2,567	+3%	+$147K	3.36%	9
2026 Q1	$6.06M	Buy	99,879 +3,809	+4%	+$222K	3.22%	8
2025 Q4	$5.18M	Buy	96,070 +1,937	+2%	+$93.2K	2.97%	9
2025 Q3	$4.25M	Buy	94,133 +5,293	+6%	+$247K	2.55%	10
2025 Q2	$4.11M	Buy	88,840 +1,814	+2%	+$89K	2.79%	11
2025 Q1	$5.31M	Buy	87,026 +1,977	+2%	+$115K	3.89%	7
2024 Q4	$4.81M	Buy	85,049 +2,378	+3%	+$133K	3.7%	8
2024 Q3	$4.28M	Buy	82,671 +8,206	+11%	+$385K	3.12%	8
2024 Q2	$3.09M	Buy	74,465 +10,684	+17%	+$478K	2.43%	13
2024 Q1	$3.46M	Buy	63,781 +16,626	+35%	+$847K	2.74%	11
2023 Q4	$2.42M	Buy	+47,155	New	+$2.48M	2.11%	13

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Thor Investment Management's BMY Position: Q2 2026 in Review

Thor Investment Management increased its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2026, buying an estimated $147K and bringing the position to 102,446 shares worth $5.9M. The position accounts for 3.36% of the portfolio, ranked #9.

Thor Investment Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.06M in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Thor Investment Management held 102,446 shares of Bristol-Myers Squibb worth $5.9M as of Q2 2026.
Thor Investment Management bought 2,567 Bristol-Myers Squibb shares in Q2 2026, an estimated $147K.
Bristol-Myers Squibb made up 3.36% of Thor Investment Management's portfolio in Q2 2026, its #9 holding.
Thor Investment Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Thor Investment Management's Bristol-Myers Squibb position peaked at $6.06M in Q1 2026.
2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Thor Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.